New anesthesia combo may reduce risks during chest surgery
NCT ID NCT07347496
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares a newer anesthesia drug, remimazolam, with the standard drug propofol (both combined with a painkiller) for people having chest surgery. The goal is to see if remimazolam causes fewer problems like low oxygen levels or low blood pressure during the operation. About 50 adults aged 18-75 will take part, and their safety and recovery will be closely monitored.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANESTHESIA are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a smart pump prevent dangerous drops in blood pressure during C-Sections?
- Can a ketamine boost during surgery slash opioid needs?
- Can a wearable glucose sensor survive the operating room?
- Can a scalp cap read the brain as well as implanted wires?
- Could a simpler nerve block keep blood sugar steady after lung surgery?
- Could a simple ventilation tweak calm lung surgery inflammation?